简介：

简介：

简介：

简介：

简介：Mobileplatformdevelopsrapidlyinrecentyears,withitsperformanceandcapacityincreasing.Alargenumberofvirtualrealityapplicationssuchas3Dsimulationandvisualizationhaveappearedonmobileplatform.However,duetorestrictions,suchasthelackofcomputingresourcesandthelimitednetworkbandwidth,thevirtualrealitysystemsonmobileplatformcouldnothavecomparableperformanceastheirpeersondesktopplatform.Takingresourcerestrictionsintoconsideration,trade-offshavebeenmaderegardingthedisplayofvirtualrealitysystems.Weproposeaunifiednetworkschedulingstrategybasedonasynchronousmulti-thread,databasecache,prioritizationandeliminationofoverduerequests.ThisstrategyhasbeentestedontheprototypesystemofvirtualrealitysystemonAndroid.Theresultsdemonstratehighernetworkresourceutilizationandbetteruserexperience.

简介：Multiplesclerosisisachronicinflammatorydiseasethatisaccompaniedbydemyelinationandaxonaldamageresultinginneurologicaldeficits.Remyelinationisthenaturalendogenousrepairmechanismofdemyelinatedaxonsanditissupposedtoprotectaxons/neuronsfromdegenerationandthusthepatientfromprogressivedisability(FranklinandFfrench-Constant,2008).Currenttherapeuticsforpatientswithmultiplesclerosis

简介：<正>Theinitiationofthe"SilkRoadEconomicBeltandthe21st-CenturyMaritimeSilkRoad"strategy（"BeltandRoad"strategy）inthefallof2013haspromotedboththeoffshoreandmaritimedevelopmentbetweenChinaanditsneighbors.Inthebeginningof201S,theChineseGovernmentofficiallyannouncedtheimplementationofthe"BeltandRoad"strategy.Asaninternational-

简介：Brainischemicstrokeistheleadingcauseoflong-lastinginjury,disability,anddeathinadults.Althoughthebrainrepresentsonlyabout2%ofthetotalbodymass,itconsumesalmost20%ofthebody’soxygen.Asaresult,braincellsareextremelysensitivetohypoxia.Oncecerebralischemiaoccurs,thecoreofthe

简介：

简介：一个热电源系统的效率能被电产生和电消费的操作的工艺的前进改进，这广泛地被认出了。聪明的米启用在顾客和电产生系统之间的双向通讯。电产生系统使用价格刺激(即在高峰时期的更高的价格和在离峰的时期的更低的价格)在聪明的格子环境下面从山峰转移要求的部分到离峰的时期。给在每个时期的那燃料消费是严格地增加的事实电源输出的凸的功能，我们求婚二时期并且多时期定价策略，和研究减少燃料消费上的不同定价策略的效果。

简介：

简介：

简介：Weinthispaperexaminewarrantystrategyinatwo-stagesupplychainconsistingofamanufacturerandtwocompetingretailers.Themanufacturerproducestwosubstituteproductsandmarketsthemthroughthetworetailerstoagroupofconsumers,respectively.Foreachtypeofproducts,themanufacturer’sbasewarrantyandaretailer’sextendedwarrantyarebundledwiththeproduct.Weusegametheoreticmodelstoexploretheinteractionsbetweenthetwotypesofwarrantiesandthecompetitionbetweentheretailers.Forthispurpose,twoscenariosareconsidered:noretailerandboththetworetailersprovidingtheextendedwarranties,respectively.Ineachscenario,themanufacturer’sbasewarrantiesareassumedtobeoffered.Ourresultsshowthatwhentheretailersoffertheirextendedwarranties,themanufacturerhasnoincentivetoofferthebasewarranties;otherwise,themanufacturerhastoprovidethebasewarranties.Thecompetitionbetweenretailersintermsoftheproductsubstitutabilityhasnoimpactonwarrantydecisions,butaffectsallplayers’profitsinthesupplychain.Themanufacturercanprovidealongerwarrantylengthandhighercustomerwelfaretoacustomerthantheretailersdo,ifitismoreefficientthantheretailersinwarrantycost-efficiency,andviceversa.

简介：

简介：Recentadvancesinstemcelltechnologieshaveopenednewavenuesforthetreatmentofanumberofdiseasesstilllackingeffectivetherapeuticoptions.Celltransplantationhasemergedasamongthemostpromisingclinicalinterventionfordisorderssuchasinjuries,diabetes,liver

简介：BackgroundComparedtoclopidogrel,Ticagrelorsignificantlyreducestheriskofcardiovasculareventsinpatientswithacutemyocardialinfarction(AMI)howeverincreasestheincidenceofbleedingandtheriskoffatalintracranialhemorrhage.Inthisstudy,wescreenedtheAMIpatientswithclopidogrelresistence,anddeterminedwhetherticagrelorsequentialtherapycouldreducetheriskofcardiovasculareventsandbleedingrisk.MethodsAtotalof319AMIpatientswereenrolledinthisprospectiveclinicalstudy.Theplateletinhibitionratesinadenosine5'-diphosphate(ADP)pathwaysweremeasuredbyathrombelastography(TEG)system.ThepatientswithclopidogrelresistanceweredividedintoTicagrelorsequentialtherapygroup(ticagrelorfor3monthsandclopidogrelfor9months,n=143)andClopidogrelgroup(clopidogrelfor12months,n=176).Theriskofmajoradversecardiacevents(MACE)andthesafetyendpointsat1-yearfollow-upwereanalyzed.ResultsTheratesofstentthrombosis(ST)(2.1%vs.8.0%,P=0.017)orMI(2.8%vs.10.2%,P=0.009)werelowerintheticagrelorsequentialtherapygroupthanintheclopidogrelgroup.Dyspneawasmoreoftenintheticagrelorsequentialtherapygroupthanintheclopidogrelgroup(17.5%vs.4.5%,P<0.001).Nosignificantdifferenceintherateofmajorbleedingwasfoundbetweenthegroups(3.4%vs.3.9%,P=0.528).ConclusionsInAMIpatientswithhyporesponsivenesstoclobidogrelticagrelorsequentialtherapygroupsignificantlydecreasedtheratesofSTandMIwithoutincreasedriskofmajorbleedingascomparedwithclopidolgrel.